-
Options Brief: MELA Sciences, Inc. (MELA)
Monday, January 3, 2011 - 12:38pm | 84Shares of MELA Sciences, Inc. (NASDAQ: MELA) are lower on the session by 3.58%, trading at $3.23. Overall put volume is now running at 2.48x the daily average, with 6% of all puts traded being purchases on the offer. 3,024 contracts have traded on the session so far. MELA Sciences, Inc., formerly...
-
Boston Scientific Sells Neurovascular Business
Monday, January 3, 2011 - 12:31pm | 105Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Neurovascular business to Stryker Corporation. The sale price is $1.5 billion, of which $1.45 billion was received at closing (including an upfront payment of $1.376 billion, a $50 million milestone...
-
Morgan Stanley Downgrades STJ To Underweight
Monday, January 3, 2011 - 11:54am | 145Morgan Stanley reports today that increasing risks to revenue outlook amid a softening CRM market drive its downgrade on shares of St. Jude Medical, Inc. (NYSE: STJ) to UW. “St. Jude's reliance on the cardiac rhythm management (CRM) market (nearly 60% of 2010e sales) has long been a key investor...
-
Morgan Stanley Initiates BCR Coverage With An EW Rating
Monday, January 3, 2011 - 11:53am | 125Morgan Stanley is initiating coverage on shares of C.R. Bard, Inc. (NYSE: BCR) with an EW rating. “Bard's premium multiple of 15x (vs. peers at 13x) is justified, given that it is insulated from structural pressures facing high-end implantable providers, continues to offer top-quartile growth, and...
-
HeartWare Files PMA for New Device - Analyst Blog
Monday, January 3, 2011 - 11:04am | 449HeartWare International (HTWR), a leading manufacturer of heart devices, recently submitted a Pre-Market Approval (“PMA”) application to the U.S. Food and Drug Administration (“FDA”), for its HeartWare Ventricular Assist System. Essentially the new device is a bridge to heart transplantation for...
-
HeartWare Files PMA for New Device - Analyst Blog
Monday, January 3, 2011 - 10:45am | 449HeartWare International (HTWR), a leading manufacturer of heart devices, recently submitted a Pre-Market Approval (“PMA”) application to the U.S. Food and Drug Administration (“FDA”), for its HeartWare Ventricular Assist System. Essentially the new device is a bridge to heart transplantation for...
-
EDAP Reduces Convertible Debt by USD 4.6 Million
Monday, January 3, 2011 - 9:37am | 81EDAP TMS SA (Nasdaq: EDAP) announced today that it entered into agreements with certain holders of its senior debentures and warrants to redeem part of EDAP's outstanding convertible debt and cancel some of its outstanding warrants. Pursuant to these agreements, the Company issued 1,441,743...
-
Orthofix International Awarded Contract
Monday, January 3, 2011 - 9:30am | 66Orthofix International N.V. (NASDAQ: OFIX) today announced that its sports medicine division, Breg, has signed a contract with Novation to be the exclusive manufacturer of cold therapy products for NOVAPLUS, the private label brand of Novation. With over 35,000 members, Novation is the largest...
-
J.P Morgan Downgrades Boston Scientific To Underweight From Neutral
Monday, January 3, 2011 - 9:12am | 247According to J.P Morgan, 2011 is shaping up to be a transition year at Boston Scientific (NYSE: BSX), as dilutive M&A offsets cost-cutting, deleveraging, and the easy comp of the March 2010 shutdown of the US ICD business. 2010 was a tough year for Boston. Continued weakness in core end...
-
J.P Morgan Upgrades NuVasive To Neutral
Monday, January 3, 2011 - 9:02am | 240As J.P Morgan looks toward 2011, the spine market outlook is still poor and visibility into Nuvasive's (NASDAQ: NUVA) sustainable growth trajectory is limited. However, Street expectations have clearly been reset, to the point where it now believes that the risk of further disappointment is limited...
-
Invacare Corporation Completes Redemption of 9¾% Senior Notes Due 2015
Monday, January 3, 2011 - 8:35am | 41Invacare Corporation (NYSE: IVC) announced today that it has completed the redemption of its outstanding 9¾% Senior Notes due 2015. In total, the Company redeemed $146,000,000 worth of the Senior Notes in the Fourth Quarter of 2010.
-
JP Morgan Downgrades C.R. Bard To Neutral
Monday, January 3, 2011 - 8:30am | 27JP Morgan has downgraded C. R. Bard Inc. (NYSE: BCR) from Overweight to Neutral and maintains its $95 price target.
-
JP Morgan Downgrades Integra LifeSciences To Neutral
Monday, January 3, 2011 - 8:03am | 30JP Morgan has downgraded Integra LifeSciences Holdings Corporation (NASDAQ: IART) from Overweight to Neutral and has raised the price target from $48 to $53.
-
JP Morgan Downgrades MAKO Surgical To Neutral
Monday, January 3, 2011 - 8:01am | 26JP Morgan has downgraded MAKO Surgical Corporation (NASDAQ: MAKO) from Overweight to Neutral and maintains its $17 price target.
-
JP Morgan Ups NUVA To Neutral
Monday, January 3, 2011 - 7:59am | 51Analysts at JP Morgan upgrade NuVasive Inc (NASDAQ: NUVA) from “underweight” to “neutral.” The target price for NUVA has been raised from $25 to $29. NUVA shares lost 1.38% to close at $25.65 on Friday. More Analyst Ratings here